Low penetrance of retinoblastoma for p.V654L mutation of the RB1 gene

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Hung, Chia Cheng ^a,b   Lin, Shin Yu ^a,b   Lee, Chien Nan ^b   Chen, Chih Ping ^c   Lin, Shuan Pei ^c   Chao, Mei Chyn ^d,e   Chiou, Shyh Shin ^d   Su, Yi Ning ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CANCER GENETICS; CHILD; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GENE MUTATION; GENETIC SCREENING; GERM LINE; HUMAN; MALE; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PEDIGREE; PENETRANCE; PHENOTYPE; PHENOTYPIC VARIATION; RETINOBLASTOMA; TAIWAN; GENETICS; MISSENSE MUTATION;

RETINOBLASTOMA PROTEIN;

DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MUTATION, MISSENSE; PEDIGREE; PENETRANCE; PHENOTYPE; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN; TAIWAN;

EID: 79957448125     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-76     Document Type: Article

References (21)

1. Macklin MT. A study of retinoblastoma in Ohio. Am J Hum Genet 1960, 12:1-43. 1932053, 14419544.
2. Pendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch Ophthalmol 1980, 98:1204-1210.
3. Gallie BL, Ellsworth RM, Abramson DH, Phillips RA. Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation?. Br J Cancer 1982, 45:513-521. 10.1038/bjc.1982.87, 2010981, 7073943.
4. Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW, Dryja TP. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 1993, 17:535-543. 10.1006/geno.1993.1368, 7902321.
5. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, Benedict WF, Yandell DW, Louis DN. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994, 36:714-721. 10.1002/ana.410360505, 7979217.
6. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971, 68:820-823. 10.1073/pnas.68.4.820, 389051, 5279523.
7. Balmer A, Zografos L, Munier F. Diagnosis and current management of retinoblastoma. Oncogene 2006, 25:5341-5349. 10.1038/sj.onc.1209622, 16936756.
8. Harbour JW. Molecular basis of low-penetrance retinoblastoma. Arch Ophthalmol 2001, 119:1699-1704.
9. Lohmann DR, Brandt B, Hopping W, Passarge E, Horsthemke B. Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum Genet 1994, 94:349-354.
10. Onadim Z, Hogg A, Baird PN, Cowell JK. Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. Proc Natl Acad Sci USA 1992, 89:6177-6181. 10.1073/pnas.89.13.6177, 402145, 1352883.
11. Bremner R, Du DC, Connolly-Wilson MJ, Bridge P, Ahmad KF, Mostachfi H, Rushlow D, Dunn JM, Gallie BL. Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am J Hum Genet 1997, 61:556-570. 10.1086/515499, 1715941, 9326321.
12. Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, Han L, Panton R, Branco P, Gallie B. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003, 72:253-269. 10.1086/345651, 379221, 12541220.
13. Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 1987, 15:7155-7174. 10.1093/nar/15.17.7155, 306199, 3658675.
14. Zhang K, Nowak I, Rushlow D, Gallie BL, Lohmann DR. Patterns of missplicing caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expression. Hum Mutat 2008, 29:475-484. 10.1002/humu.20664, 18181215.
15. Valverde JR, Alonso J, Palacios I, Pestana A. RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database. BMC Genet 2005, 6:53. 1298292, 16269091.
16. Abouzeid H, Schorderet DF, Balmer A, Munier FL. Germline mutations in retinoma patients: relevance to low-penetrance and low-expressivity molecular basis. Mol Vis 2009, 15:771-777. 2671583, 19390654.
17. Matsunaga E. Hereditary retinoblastoma: delayed mutation or host resistance?. Am J Hum Genet 1978, 30:406-424. 1685630, 717402.
18. Dryja TP, Rapaport J, McGee TL, Nork TM, Schwartz TL. Molecular etiology of low-penetrance retinoblastoma in two pedigrees. Am J Hum Genet 1993, 52:1122-1128. 1682279, 8099255.
19. Sakai T, Ohtani N, McGee TL, Robbins PD, Dryja TP. Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature 1991, 353:83-86. 10.1038/353083a0, 1881452.
20. Gallie BL, Hei Y-J, JM D. Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. 1995,
21. Cowell JK, Bia B, Akoulitchev A. A novel mutation in the promotor region in a family with a mild form of retinoblastoma indicates the location of a new regulatory domain for the RB1 gene. Oncogene 1996, 12:431-436.